Hannah Ensor

1.2k total citations
18 papers, 794 citations indexed

About

Hannah Ensor is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Hannah Ensor has authored 18 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in Hannah Ensor's work include Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Hannah Ensor is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Hannah Ensor collaborates with scholars based in United Kingdom, China and Greece. Hannah Ensor's co-authors include Anthony V. Moorman, Lucy Chilton, Christine J. Harrison, Claire Schwab, Sally E. Kinsey, Sue Richards, Ajay Vora, Stephen J. Proctor, Jennifer Wilkinson and Nick Bown and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hannah Ensor

16 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah Ensor United Kingdom 10 627 527 317 92 69 18 794
Anja Moericke Germany 12 451 0.7× 312 0.6× 224 0.7× 95 1.0× 83 1.2× 24 618
MJ Willemse Netherlands 13 569 0.9× 490 0.9× 169 0.5× 90 1.0× 100 1.4× 13 805
Anna Hassebroek United States 10 155 0.2× 268 0.5× 73 0.2× 51 0.6× 102 1.5× 23 485
Caitlin R. Rausch United States 13 267 0.4× 559 1.1× 75 0.2× 276 3.0× 278 4.0× 51 1.0k
Jeanette Seyfarth Denmark 7 277 0.4× 240 0.5× 126 0.4× 99 1.1× 25 0.4× 8 716
Francesca Ronco Italy 14 156 0.2× 386 0.7× 57 0.2× 67 0.7× 122 1.8× 40 536
Elisa Dorantes‐Acosta Mexico 11 168 0.3× 192 0.4× 56 0.2× 115 1.3× 128 1.9× 36 430
Angéla Granata France 19 186 0.3× 679 1.3× 60 0.2× 46 0.5× 300 4.3× 61 863
B. Völkers Germany 10 165 0.3× 411 0.8× 44 0.1× 90 1.0× 133 1.9× 14 558
Hiroshi Sao Japan 15 163 0.3× 597 1.1× 74 0.2× 76 0.8× 125 1.8× 40 912

Countries citing papers authored by Hannah Ensor

Since Specialization
Citations

This map shows the geographic impact of Hannah Ensor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Ensor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Ensor more than expected).

Fields of papers citing papers by Hannah Ensor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Ensor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Ensor. The network helps show where Hannah Ensor may publish in the future.

Co-authorship network of co-authors of Hannah Ensor

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Ensor. A scholar is included among the top collaborators of Hannah Ensor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Ensor. Hannah Ensor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Urquhart, Don S., Emily P. Taylor, Steve Cunningham, et al.. (2025). Safety, feasibility and efficacy of exercise as an airway clearance technique in cystic fibrosis: a randomised pilot feasibility trial. Thorax. 81(2). 140–149.
3.
White, James, Christopher J. Weir, Andrew Stoddart, et al.. (2025). Preventing gambling-related harm among adolescents (PRoGRAM-A): an embedded multi-modal process evaluation in a pilot cluster random control trial. BMC Public Health. 25(1). 2327–2327. 1 indexed citations
4.
Mead, Gillian, David Gillespie, Mark Barber, et al.. (2022). Post stroke intervention trial in fatigue (POSITIF): Randomised multicentre feasibility trial. Clinical Rehabilitation. 36(12). 1578–1589. 13 indexed citations
5.
Reed, Matthew J., Rachel O’Brien, Polly Black, et al.. (2021). Physiological deterioration in the Emergency Department: The SNAP40-ED study. SHILAP Revista de lepidopterología. 17(3). 1 indexed citations
6.
Ensor, Hannah & Christopher J. Weir. (2021). Separation and the information theory surrogate evaluation approach: A penalised likelihood solution. Pharmaceutical Statistics. 21(1). 55–68. 1 indexed citations
7.
Ensor, Hannah & Christopher J. Weir. (2019). Evaluation of surrogacy in the multi-trial setting based on information theory: an extension to ordinal outcomes. Journal of Biopharmaceutical Statistics. 30(2). 364–376. 2 indexed citations
8.
Livingstone, Morag, Nick Wheelhouse, Hannah Ensor, et al.. (2017). Pathogenic outcome following experimental infection of sheep with Chlamydia abortus variant strains LLG and POS. PLoS ONE. 12(5). e0177653–e0177653. 18 indexed citations
9.
Ensor, Hannah, et al.. (2017). Evidence-based Pediatric Orthopaedics: How Safe is “Safe”?. Journal of Pediatric Orthopaedics. 37(7). e440–e445. 1 indexed citations
10.
Wells, Beth, Sarah Thomson, Hannah Ensor, Elisabeth A. Innes, & Frank Katzer. (2016). Development of a sensitive method to extract and detect low numbers of Cryptosporidium oocysts from adult cattle faecal samples. Veterinary Parasitology. 227. 26–29. 21 indexed citations
11.
Ensor, Hannah, Robert J. Lee, Cathie Sudlow, & Christopher J. Weir. (2015). Statistical approaches for evaluating surrogate outcomes in clinical trials: A systematic review. Journal of Biopharmaceutical Statistics. 26(5). 859–879. 14 indexed citations
12.
Moorman, Anthony V., Claire Schwab, Hannah Ensor, et al.. (2012). IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 30(25). 3100–3108. 88 indexed citations
13.
Sinclair, Paul, Helen Parker, Qian An, et al.. (2011). Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy. Human Molecular Genetics. 20(13). 2591–2602. 26 indexed citations
14.
Rand, Vikki, Helen Parker, Lisa J. Russell, et al.. (2011). Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 117(25). 6848–6855. 83 indexed citations
15.
Moorman, Anthony V., Hannah Ensor, Sue Richards, et al.. (2010). Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. The Lancet Oncology. 11(5). 429–438. 256 indexed citations
16.
Moorman, Anthony V., Lucy Chilton, Jennifer Wilkinson, et al.. (2010). Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England. Blood. 116(6). 1012–1012. 1 indexed citations
17.
Ensor, Hannah, Claire Schwab, Lisa J. Russell, et al.. (2010). Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood. 117(7). 2129–2136. 104 indexed citations
18.
Moorman, Anthony V., Lucy Chilton, Jennifer Wilkinson, et al.. (2009). A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 115(2). 206–214. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Moericke Breakdown of academic impact, for papers by MJ Willemse Breakdown of academic impact, for papers by Anna Hassebroek Breakdown of academic impact, for papers by Caitlin R. Rausch Breakdown of academic impact, for papers by Jeanette Seyfarth Breakdown of academic impact, for papers by Francesca Ronco Breakdown of academic impact, for papers by Elisa Dorantes‐Acosta Breakdown of academic impact, for papers by Angéla Granata Breakdown of academic impact, for papers by B. Völkers Breakdown of academic impact, for papers by Hiroshi Sao
Rankless by CCL
2026